| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Karin Ardjomand-Woelkart | Q120542862 |
| Rudolf Bauer | Q37376746 | ||
| Klaus Linde | Q42305790 | ||
| P2093 | author name string | Bruce Barrett | |
| Marlies Karsch-Völk | |||
| David Kiefer | |||
| P2860 | cites work | [Treatment of radiation-induced leukopenia with Esberitox] | Q71528901 |
| In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species | Q72306936 | ||
| Echinacea and truth in labeling | Q73132460 | ||
| A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections | Q77407509 | ||
| Adverse reactions associated with echinacea: the Australian experience | Q77555713 | ||
| [Nonspecific therapy with irritants for infection prophylaxis. A study of the therapeutic effect of Esberitox.] | Q78876006 | ||
| Echinacea purpurea for prevention of experimental rhinovirus colds | Q80117449 | ||
| Echinacea purpurea and mucosal immunity | Q80162684 | ||
| Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system | Q80330589 | ||
| Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans | Q80607084 | ||
| Effect of Echinacea purpurea (Asteraceae) aqueous extract on antibody response to Bothrops asper venom and immune cell response | Q81216385 | ||
| [Effectiveness of echinacin in therapy of chronic recurrent respiratory disease] | Q81692161 | ||
| A comparison of the immunostimulatory effects of the medicinal herbs Echinacea, Ashwagandha and Brahmi | Q84211269 | ||
| Efficacy of complex herbal compound of Echinacea angustifolia (Imoviral® Junior) in recurrent upper respiratory tract infections during pediatric age: preliminary results | Q84306624 | ||
| Effects of Echinaforce® treatment on ex vivo-stimulated blood cells | Q84501369 | ||
| Garlic for the common cold | Q24201242 | ||
| Vitamin C for preventing and treating the common cold | Q24201652 | ||
| Zinc for the common cold | Q24201930 | ||
| Heated, humidified air for the common cold | Q24202292 | ||
| Probiotics for preventing acute upper respiratory tract infections | Q24234353 | ||
| Saline nasal irrigation for acute upper respiratory tract infections | Q24236578 | ||
| Advising patients to increase fluid intake for treating acute respiratory infections | Q24236715 | ||
| Pelargonium sidoides extract for acute respiratory tract infections | Q24242636 | ||
| Echinacea for preventing and treating the common cold | Q24244680 | ||
| Chinese medicinal herbs for the common cold | Q24246283 | ||
| The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Oral administration of freshly expressed juice of Echinacea purpurea herbs fail to stimulate the nonspecific immune response in healthy young men: results of a double-blind, placebo-controlled crossover study | Q28198183 | ||
| Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trial | Q28217793 | ||
| An evaluation of Echinacea angustifolia in experimental rhinovirus infections | Q28263970 | ||
| Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial | Q28266919 | ||
| Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis | Q28307738 | ||
| Echinacea purpurea and osteopathic manipulative treatment in children with recurrent otitis media: a randomized controlled trial. | Q33373512 | ||
| Echinacea for upper respiratory infection. | Q33738282 | ||
| Echinacea purpurea along with zinc, selenium and vitamin C to alleviate exacerbations of chronic obstructive pulmonary disease: results from a randomized controlled trial | Q33742658 | ||
| Medicinal properties of Echinacea: a critical review | Q33845969 | ||
| Echinacea for preventing and treating the common cold. | Q33908839 | ||
| Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. | Q33974381 | ||
| Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial | Q33975378 | ||
| Ineffectiveness of echinacea for prevention of experimental rhinovirus colds | Q33979856 | ||
| Synergetic effects of oral administration of levamisole and Echinacea purpurea on immune response in Wistar rat. | Q34023645 | ||
| Immunomodulation with echinacea - a systematic review of controlled clinical trials | Q34034578 | ||
| An explanation for the seasonality of acute upper respiratory tract viral infections | Q34122415 | ||
| Does the extract of the plant Echinacea purpurea influence the clinical course of recurrent genital herpes? | Q34170026 | ||
| The economic burden of non-influenza-related viral respiratory tract infection in the United States | Q34177410 | ||
| Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways | Q34369966 | ||
| The safety of herbal medicinal products derived from Echinacea species: a systematic review | Q34413871 | ||
| Treatment of the common cold with echinacea: a structured review | Q34555469 | ||
| Randomized trial of a fixed combination (KanJang) of herbal extracts containing Adhatoda vasica, Echinacea purpurea and Eleutherococcus senticosus in patients with upper respiratory tract infections | Q34560390 | ||
| Open, multicenter study to evaluate the tolerability and efficacy of Echinaforce Forte tablets in athletes | Q34572951 | ||
| Efficacy and safety of a multiherbal formula with vitamin C and zinc (Immumax) in the management of the common cold | Q34622604 | ||
| Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial | Q34643340 | ||
| Echinacea for treating the common cold: a randomized trial | Q34665639 | ||
| Placebo Effects and the Common Cold: A Randomized Controlled Trial | Q35097170 | ||
| Randomised, double blind, placebo-controlled trial of echinacea supplementation in air travellers | Q35645820 | ||
| Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials | Q35648461 | ||
| Echinacea/sage or chlorhexidine/lidocaine for treating acute sore throats: a randomized double-blind trial | Q35959069 | ||
| Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. | Q36470152 | ||
| Echinacea in infection | Q36488933 | ||
| Enhancement of innate and adaptive immune functions by multiple Echinacea species | Q36617061 | ||
| The role of alkamides as an active principle of echinacea | Q36835608 | ||
| Identifying relevant studies for systematic reviews | Q36888457 | ||
| Effects of chemically characterized fractions from aerial parts of Echinacea purpurea and E. angustifolia on myelopoiesis in rats | Q37088260 | ||
| Echinacea sanguinea and Echinacea pallida extracts stimulate glucuronidation and basolateral transfer of Bauer alkamides 8 and 10 and ketone 24 and inhibit P-glycoprotein transporter in Caco-2 cells | Q37134477 | ||
| Endogenous levels of Echinacea alkylamides and ketones are important contributors to the inhibition of prostaglandin E2 and nitric oxide production in cultured macrophages. | Q37421665 | ||
| Modulation of immune response gene expression by echinacea extracts: results of a gene array analysis | Q38295550 | ||
| The efficacy of Prrrikweg gel in the treatment of insect bites: a double-blind, placebo-controlled clinical trial. | Q39067802 | ||
| A placebo controlled clinical trial investigating the efficacy of a homeopathic after-bite gel in reducing mosquito bite induced erythema | Q39067807 | ||
| Efficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trial | Q39415629 | ||
| Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract | Q39857810 | ||
| Echinacea alkylamides modulate induced immune responses in T-cells | Q40081213 | ||
| The clinical impact of human respiratory virus infections | Q40408330 | ||
| Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study | Q40539304 | ||
| The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study | Q40615497 | ||
| Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial | Q40835053 | ||
| Results of Five Randomized Studies on the Immunomodulatory Activity of Preparations of Echinacea | Q40979348 | ||
| Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections | Q42639157 | ||
| The anxiolytic potential and psychotropic side effects of an echinacea preparation in laboratory animals and healthy volunteers. | Q42641602 | ||
| Effects ofEchinaceaextract on the performance, antibody titres, and intestinal histology of layer chicks | Q42777894 | ||
| Immunological activity of larch arabinogalactan and Echinacea: a preliminary, randomized, double-blind, placebo-controlled trial. | Q43352859 | ||
| Anti-inflammatory effects of essential oil in Echinacea purpurea L | Q43442100 | ||
| Use of a standardized extract from Echinacea angustifolia (Polinacea) for the prevention of respiratory tract infections | Q43674216 | ||
| Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study | Q43859911 | ||
| Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study | Q44244948 | ||
| Echinacea purpurea for prevention of upper respiratory tract infections in children | Q45166070 | ||
| Effect of oral application of an immunomodulating plant extract on Influenza virus type A infection in mice | Q45178254 | ||
| Echinacea purpurea polysaccharide reduces the latency rate in herpes simplex virus type-1 infections | Q45385280 | ||
| Drug modification of the phagocytic capacity of granulocytes | Q45805563 | ||
| Effects of echinacea on the frequency of upper respiratory tract symptoms: a randomized, double-blind, placebo-controlled trial | Q46279744 | ||
| Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans | Q46497120 | ||
| Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion | Q46512377 | ||
| The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots | Q46687217 | ||
| A proprietary extract from the echinacea plant (Echinacea purpurea) enhances systemic immune response during a common cold | Q46715664 | ||
| A randomized, double-blind, placebo-controlled, clinical dose-response trial of an extract of Baptisia, Echinacea and Thuja for the treatment of patients with common cold | Q47681123 | ||
| Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children | Q48025565 | ||
| The effects of an Echinacea preparation on synaptic transmission and the firing properties of CA1 pyramidal cells in the hippocampus | Q49108941 | ||
| Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts | Q51756524 | ||
| Incidence of banal infections in childhood and possibilities of their prevention | Q54245284 | ||
| Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial. | Q55033009 | ||
| Effects of Ginseng and Echinacea on Cytokine mRNA Expression in Rats | Q58915145 | ||
| Placebo-controlled, double-blind study of Echinaceae pallidae radix in upper respiratory tract infections | Q59569221 | ||
| [Effect of homeopathic drugs on the phagocytic activity of human granulocytes. In vitro tests in a controlled single-blind study] | Q68921700 | ||
| [Additional treatment with Esberitox N in patients with chemo-radiotherapy treatment of advanced breast cancer] | Q69124905 | ||
| [Efficacy of Esberitox in the treatment of radiation-induced leukopenia] | Q69190645 | ||
| [An experiment to decrease susceptibility to infections in young children with Esberitox] | Q69982350 | ||
| Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes | Q70183340 | ||
| Determination of the activity of extracts of Echinaceae and Sabal in the treatment of idiopathic megabladder in women | Q70235350 | ||
| [Supplementary treatment with Esberitox of female patients undergoing curative adjuvant irradiation following breast cancer] | Q70390534 | ||
| [Effect on the frequency of banal cold infections by esberitox] | Q71020798 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | common cold | Q12125 |
| P304 | page(s) | CD000530 | |
| P577 | publication date | 2014-02-20 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Echinacea for preventing and treating the common cold | |
| P478 | volume | 2 |
| Q38737694 | A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies |
| Q39693240 | Activities and Prevalence of Proteobacteria Members Colonizing Echinacea purpurea Fully Account for Macrophage Activation Exhibited by Extracts of This Botanical |
| Q39067599 | Analyzing user-generated online content for drug discovery: development and use of MedCrawler. |
| Q40899737 | Antagonistic interactions between endophytic cultivable bacterial communities isolated from the medicinal plant Echinacea purpurea. |
| Q26823561 | Antibiotic Resistance: What are the Opportunities for Primary Care in Alleviating the Crisis? |
| Q64113413 | Beliefs, practices and knowledge of community pharmacists regarding complementary and alternative medicine: national cross-sectional study in Lebanon |
| Q64105639 | Binafuxi granules in the treatment of common cold with heat syndrome based on traditional Uighur medicine: study protocol for a multicenter randomized controlled trial |
| Q64229391 | Bridging the divide between causal illusions in the laboratory and the real world: the effects of outcome density with a variable continuous outcome |
| Q96109508 | Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020 |
| Q28072523 | Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology |
| Q38607315 | Complementary and alternative medicine therapies for the anesthesiologist and pain practitioner: a narrative review |
| Q56980574 | Echinacea for preventing and treating the common cold |
| Q42423744 | Echinacea-associated acute cholestatic hepatitis |
| Q93345208 | Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children |
| Q28546956 | Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria |
| Q24188030 | Garlic for the common cold |
| Q56852327 | Heated, humidified air for the common cold |
| Q57688798 | Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children |
| Q53279053 | Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children. |
| Q92669415 | Immunity-targeted approaches to the management of chronic and recurrent upper respiratory tract disorders in children |
| Q94688710 | Maintaining Health and Well-Being by Putting Faith into Action During the COVID-19 Pandemic |
| Q40899558 | Pregnancy outcomes after prenatal exposure to echinacea: the Norwegian Mother and Child Cohort Study |
| Q55072787 | Principles of pharmacological research of nutraceuticals. |
| Q40761385 | Purple coneflower as antiviral agent |
| Q51733266 | Randomised controlled trial of rhinothermy for treatment of the common cold: a feasibility study |
| Q55024821 | Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosa |
| Q64248910 | The Contribution of Complementary and Alternative Medicine to Reduce Antibiotic Use: A Narrative Review of Health Concepts, Prevention, and Treatment Strategies |
| Q92029807 | Treatment of signs and symptoms of the common cold using EPs 7630 - results of a meta-analysis |
| Q90383502 | Unraveling the Molecular Mechanism of Traditional Chinese Medicine: Formulas Against Acute Airway Viral Infections as Examples |
| Q85735649 | [Herbal medicines: when to use or not to use?] |
Search more.